Dow Up 0.11% Nasdaq Up 0.50%

Seattle Genetics Inc. (SGEN)

-NasdaqGS
44.01 Up 0.44(1.01%) Aug 29, 4:00PM EDT
|After Hours : 44.25 Up 0.24 (0.55%) Aug 29, 7:58PM EDT
Prev Close:43.57
Open:43.64
Bid:42.00 x 100
Ask:44.90 x 2000
1y Target Est:44.75
Beta:1.28
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:43.19 - 44.08
52wk Range:32.35 - 55.99
Volume:523,020
Avg Vol (3m):998,923
Market Cap:5.43B
P/E (ttm):N/A
EPS (ttm):-0.51
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SGENUp 1.01%5.43B
IMGNUp 1.37%1.02B
PFEUp 0.03%186.36B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):19.56
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.80
Quarterly EPS Est (Sep-14) :-0.24
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):-7.05

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Seattle Genetics, Inc., a biotechnology company, develops and commercializes antibody-based therapies for the treatment of cancer. The company is developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback